Literature DB >> 10455124

Characterization of the carboxyl-terminal domain of the rat glucose-dependent insulinotropic polypeptide (GIP) receptor. A role for serines 426 and 427 in regulating the rate of internalization.

M B Wheeler1, R W Gelling, S A Hinke, B Tu, R A Pederson, F Lynn, J Ehses, C H McIntosh.   

Abstract

Glucose-dependent insulinotropic polypeptide (GIP) is a gastrointestinal hormone involved in the regulation of insulin secretion. In non-insulin-dependent diabetes mellitus insulin responses to GIP are blunted, possibly due to altered signal transduction or reduced receptor number. Site-directed mutagenesis was used to construct truncated GIP receptors to study the importance of the carboxyl-terminal tail (CT) in binding, signaling, and receptor internalization. Receptors truncated at amino acids 425, 418, and 405, expressed in COS-7 or CHO-K1 cells, exhibited similar binding to wild type receptors. GIP-dependent cAMP production with the 405 mutant was decreased in COS-7 cells. Maximal cAMP production in CHO-K1 cells was reduced with all truncated forms. Binding was undetectable with a receptor truncated at amino acid 400; increasing tail length by adding 5 alanines restored binding and signaling. Mutants produced by alanine scanning of residues 394-401, adjacent to transmembrane domain 7, were all functional. CT truncation by 30 or more amino acids, mutation of serines 426/427, singly or combined, or complete CT serine knockout all reduced receptor internalization rate. The majority of the GIP receptor CT is therefore not required for signaling, a minimum chain length of approximately 405 amino acids is needed for receptor expression, and serines 426 and 427 are important for regulating rate of receptor internalization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10455124     DOI: 10.1074/jbc.274.35.24593

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Downregulation of a GPCR by β-Arrestin2-Mediated Switch from an Endosomal to a TGN Recycling Pathway.

Authors:  Nazish Abdullah; Muheeb Beg; David Soares; Jeremy S Dittman; Timothy E McGraw
Journal:  Cell Rep       Date:  2016-12-13       Impact factor: 9.423

2.  Functional consequences of glucagon-like peptide-1 receptor cross-talk and trafficking.

Authors:  Sarah Noerklit Roed; Anne Cathrine Nøhr; Pernille Wismann; Helle Iversen; Hans Bräuner-Osborne; Sanne Moeller Knudsen; Maria Waldhoer
Journal:  J Biol Chem       Date:  2014-12-01       Impact factor: 5.157

Review 3.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

4.  Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor.

Authors:  Christoph Parthier; Martin Kleinschmidt; Piotr Neumann; Rainer Rudolph; Susanne Manhart; Dagmar Schlenzig; Jörg Fanghänel; Jens-Ulrich Rahfeld; Hans-Ulrich Demuth; Milton T Stubbs
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-21       Impact factor: 11.205

5.  Conserved extracellular cysteine residues and cytoplasmic loop-loop interplay are required for functionality of the heptahelical MLO protein.

Authors:  Candace Elliott; Judith Müller; Marco Miklis; Riyaz A Bhat; Paul Schulze-Lefert; Ralph Panstruga
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

6.  Pancreatic Beta Cell G-Protein Coupled Receptors and Second Messenger Interactions: A Systems Biology Computational Analysis.

Authors:  Leonid E Fridlyand; Louis H Philipson
Journal:  PLoS One       Date:  2016-05-03       Impact factor: 3.240

Review 7.  Plasticity of the beta cell insulin secretory competence: preparing the pancreatic beta cell for the next meal.

Authors:  Simon A Hinke; Karine Hellemans; Frans C Schuit
Journal:  J Physiol       Date:  2004-06-04       Impact factor: 5.182

8.  Characterization and modulation of the transferrin receptor on brain capillary endothelial cells.

Authors:  Corine C Visser; L Heleen Voorwinden; Daan J A Crommelin; Meindert Danhof; Albertus G de Boer
Journal:  Pharm Res       Date:  2004-05       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.